the aid library

LIST OPTIONS

Filter

932

Africa’s Health Financing in a New Era

Africa Centres for Disease Control and Prevention (Africa CDC) (2025) CC

Africa’s health sector is facing an unprecedented financing crisis, driven by a sharp decline of 70% in Official Development Assistance (ODA) from 2021 to 2025 and deep-rooted structural vulnerabilities. This collapse is placing immense pressure on Africa’s already fragile health systems as ODA ...is seen as the backbone of critical health programs: pandemic preparedness, maternal and child health services, disease control programs are all at risk, threatening Sustainable Development Goal 3 and Universal Health Coverage. Compounding this is Africa’s spiraling debt, with countries expected to service USD 81 billion by 2025—surpassing anticipated external financing inflows—further eroding fiscal space for health investments. Level of domestic resources is low. TThe Abuja Declaration of 2001, a pivotal commitment made by African Union (AU) member states, aimed to reverse this trend by pledging to allocate at least 15% of national budgets to the health sector. However, more than two decades later, only three countries—Rwanda, Botswana, and Cabo Verde—have consistently met or exceeded this target (WHO, 2023). In contrast, over 30 AU member states remain well below the 10% benchmark, with some allocating as little as 5–7% of their national budgets to health. In addition, only 16 (29%) of African countries currently have updated versions of National Health Development Plan (NHDP) supported by a National Health Financing Plan (NHFP). These two documents play a critical role in driving internal resource mobilisation. At the same time, public health emergencies are surging, rising 41%—from 152 in 2022 to 213 in 2024—exposing severe under-resourcing of health infrastructure and workforce. Recurring outbreaks (Mpox, Ebola, cholera, measles, Marburg…) alongside effects of climate change and humanitarian crises in Eastern DRC, the Sahel, and Sudan, are overwhelming systems stretched by chronic underfunding. The situation is worsened by Africa’s heavy dependency with over 90% of vaccines, medicines, and diagnostics being externally sourced—leaving countries vulnerable to global supply chain shocks. Health worker shortages persist, with only 2.3 professionals per 1,000 people (below the WHO’s recommended 4.45), and fewer than 30% of systems are digitized, undermining disease surveillance and early warning. Without decisive action, Africa CDC projects the continent could reverse two decades of health progress, face 2 to 4 million additional preventable deaths annually, and a heightened risk of a pandemic emerging from within. Furthermore, 39 million more Africans could be pushed into poverty by 2030 due to intertwined health and economic shocks. This is not just a sectoral crisis—it is an existential threat to Africa’s political, social, and economic resilience, and global stability. In response, African leaders, under Africa CDC’s stewardship, are advancing a comprehensive three-pillar strategy centered on domestic resource mobilization, innovative financing, and blended finance. more

Download (391)

View PDF (497)

Guidance on mainstreaming biodiversity for nutrition and health

World Health Organization WHO (2020) C_WHO

This report aims to support countries in the necessary transition toward healthier, more sustainable diets by integrating biodiversity in food-based interventions to support nutrition and health. It is intended to help guide decision-makers in the health, nutrition and other sectors, to: Consider... more

Download (1795)

View PDF (2852)

Guide to Good Prescribing (English version)

World Health Organization (WHO) (1994) C_WHO

A practical manual - The book provides step by step guidance to the process of rational prescribing, together with many illustrative examples. It teaches skills that are necessary throughout a clinical career.

Download (613)

View PDF (1563)

Botswana: Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC)

John Botsang World Health Organisation (WHO) (2009) C2

Download (2109)

View PDF (1047)

Tanzania: GUIDELINES ON SUBMISSION OF DOCUMENTATION FOR REGISTRATION OF HUMAN PHARMACEUTICAL PRODUCTS

Tanzania Food & Drugs Authority (TFDA) (2015) C2

First Edition

Download (670)

View PDF (1202)

Uganda: THE NATIONAL DRUG POLICY AND AUTHORITY (REGISTRATION) REGULATIONS, 2014

The Government of Uganda The Uganda Gazette (2014) C2

Download (679)

View PDF (587)

National Essential Diagnostic List
recommended

Indian Council of Medical Research India (2019) CC

Download (807)

View PDF (1144)

WHO Global Surveillance and Monitoring System for substandard and falsified medical products. Executive Summary

World Health Organization WHO (2017) C_WHO

Download (1052)

View PDF (902)

Laws of Kenya- - PHARMACY AND POISONS ACT

National Council for Law Reporting with the Authority of the Attorney-General Kenya Law Reports (KLR) (2012) C2

CHAPTER 244

Download (749)

View PDF (1341)

WHO Global Surveillance and Monitoring System for substandard and falsified medical products

World Health Organization WHO (2017) C_WHO

Download (279)

View PDF (436)

Human Drug Compounding Progress Report

FDA US Food & Drug Administration (2017) C1

Three Years After Enactment of the Drug Quality and Security Act

Download (483)

View PDF (862)

Report of the Task Force on Conservation & Sustainable use of Medicinal Plants

Government of India, Planning Commission (2000) C1

Medicinal plants occupied an important position in the socio-cultural, spiritual and medicinal arena of rural people of India. T The present report is based on contribution made by members of the task force and many other experts on medicinal plants. We hope the report on implementation will promot... more

Download (787)

View PDF (1154)

Sierra Leone: GUIDELINES FOR MEDICINAL PRODUCT REGISTRATION

Pharmacy Board of Sierra Leone (PBSR) (2015) C2

Download (627)

View PDF (1171)

Nepal: National Drug Policy 1995

Ministry of Health, Department of Drug Administration (1995) C1

External Link

Investigation of the Quality of the 12 Most-Used Antibiotics Available in Retail Private Pharmacies in Rwanda

Bizimana, T.; Kagisha, V.; Nyandwi, J.B: et al. MDPI Antibiotics (2022) CC

Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329. The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ... more